PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran. a-talasaz@tums.ac.ir.\', \'Department of Clinical Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. a-talasaz@tums.ac.ir.\', \'Department of Clinical Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.\', \'Department of Pharmacotherapy and Outcome Science, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, USA.\', \'Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, USA.\', \'Cardiovascular Intervention Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.\', \'University of Virginia Health System, Charlottesville, VA, USA.\', \'Department of Cardiology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s10557-020-07037-2
?:hasPublicationType
?:journal
  • Cardiovascular drugs and therapy
is ?:pmid of
?:pmid
?:pmid
  • 32671601
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.349
?:rankingScore_hIndex
  • 61
is ?:relation_isRelatedTo_publication of
?:title
  • Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32671601>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32671601>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all